← Evidence map

TrialJournal of neurodevelopmental disorders2026

Gaboxadol increases resting theta and alpha power without affecting evoked responses in fragile X syndrome in a home-based setting.

Lisa A De Stefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 42104256